All In Biotech

Drug Trial Radar · NCT06706622

A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 401 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

401

Actual

Start

Dec 3, 2024

Primary completion

Feb 17, 2028

Study completion Oct 25, 2029

Sponsor

Lead sponsor
H. Lundbeck A/SIndustry
Sponsor type
Industry
First posted
Nov 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main goal of this trial is to evaluate the efficacy and safety of amlenetug for the treatment of participants with Multiple System Atrophy (MSA).

Conditions

  • Multiple System Atrophy

Interventions

  • AmlenetugDrug

    Solution for infusion

  • PlaceboDrug

    Commercially available saline solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rest of the World (RoW; All Countries Except European Union [EU] and Japan [JP]) Regional-specific Outcome Measure: Mortality-adjusted Clinical ProgressionTime frame: Baseline up to Week 72
  2. EU and JP Regional-specific Outcome Measure: Mortality-adjusted Clinical ProgressionTime frame: Baseline up to Week 72

Locations

74 sites in 10 countries. Site status is shown where the registry gives one.

  • Mayo Clinic - Vascular Center - Arizona

    Phoenix, Arizona

  • University of Arkansas for Medical Sciences (UAMS) - Medical Center

    Little Rock, Arkansas

  • University of California San Francisco - Sandler Neurosciences Center

    San Francisco, California

  • CenExel CBH - CenExel Rocky Mountain Clinical Research (CenExel RMCR) (Rocky Mountain Movement Di...

    Englewood, Colorado

  • Yale New Haven Health System

    New Haven, Connecticut

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida

  • University of Florida-College of Medicine - Gainesville

    Gainesville, Florida

  • Indiana University (IU) Health-Senior Health Center

    Indianapolis, Indiana

  • Johns Hopkins University School of Medicine - The Johns Hopkins Multiple Sclerosis (MS) Center

    Baltimore, Maryland

  • Brigham and Women's Hospital (BWH)

    Boston, Massachusetts

  • Harvard Medical School - Beth Israel Deaconess Medical Center (BIDMC) - West Campus

    Boston, Massachusetts

  • QUEST Research Institute

    Farmington, Michigan

  • Mayo Clinic - Children's Center - Rochester

    Rochester, Minnesota

  • University of Nebraska Medical Center (UNMC) - The Lied Transplant Center

    Omaha, Nebraska

  • NYU Langone Health (NYU Langone Medical Center)

    New York, New York

  • Columbia University Irving Medical Center - The Neurological Institute of New York

    New York, New York

  • Cleveland Clinic - Neurological Institute - Cerebrovascular Center

    Cleveland, Ohio

  • University of Pennsylvania - Penn Comprehensive Neuroscience Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center-Magee-Womens Hospital (MWH)

    Pittsburgh, Pennsylvania

  • Vanderbilt University Medical Center (VUMC) - Vanderbilt Orthopaedic Institute-Nashville

    Nashville, Tennessee

  • University of Texas Southwestern Medical Center (UT Southwestern Medical Center)

    Dallas, Texas

  • Baylor College of Medicine (BCM)

    Houston, Texas

  • Inland Northwest Research (INWR)

    Spokane, Washington

  • University of New South Wales-Liverpool Hospital - Liverpool Cancer Therapy Centre

    Liverpool, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Gold Coast University Hospital (GCUH) (Gold Coast Hospital)

    Southport, Queensland, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • The Ottawa Hospital - Centre for Rehabilitation Research and Development (CRRD) (The Institute fo...

    Ottawa, Ontario, Canada

  • University Health Network-Toronto Western Hospital - Krembil Neuroscience Centre (KNC)

    Toronto, Ontario, Canada

  • AP-HM- Hôpital de La Timone

    Marseille, France

  • CHU de la Pitié-Salpêtrière

    Paris, France

  • Centre Hospitalier Universitaire de Rennes-Hopital Pontchaillou

    Rennes, Brittany Region, France

  • Centre Hospitalier Universitaire de Lille (CHU Lille) - Centre Regional de Pharmacovigilance (CRPV)

    Lille, Hauts-de-France, France

  • Centre Hospitalier Universitaire (CHU) de Bordeaux - Groupe Hospitalier Pellegrin - Tripode

    Bordeaux, New Aquitaine, France

  • Centre Hospitalier Universitaire de Montpellier (CHU Montpellier)

    Montpellier, Occitanie, France

  • Centre Hospitalier Universitaire de Toulouse-Hopital Purpan

    Toulouse, Occitanie, France

  • Movement Disorders Clinic Beelitz-Heilstätten

    Beelitz-Heilstätten, Germany

  • Universitaetsklinikum Tuebingen - Universitaetsklinik fuer Psychiatrie und Psychotherapie

    Tübingen, Baden-Wurttemberg, Germany

  • Universitaetsklinikum Erlangen - Psychiatrische und Psychotherapeutische Klinik

    Erlangen, Bavaria, Germany

  • Curiositas Ad Sanum - Haag In Oberbayern

    Haag I.Ob, Bavaria, Germany

Showing 40 of 74 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.